Latest Period
Q1 2026
CUSIP: 56270V205
Latest Period
Q1 2026
Institutions Reporting
18
Shares (Excl. Options)
826,477
Price
$0.36
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
Latest holder context comes from 18 institutions filings for Q1 2026.
Security key
56270V205
Latest holder period
Q1 2026
13F holders
18
13D/G owners
2
CIK / CUSIP context first
Broader feeds
Open recent reporting periods for CUSIP 56270V205:
13D/G owners
Large-stake holder rows connected to Schedule 13D/G evidence.
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Cohen Jacob D. | 15% | +33% | $4,599,801 | +$2,526,052 | 2,044,356 | +122% | Jacob D. Cohen | 21 Jul 2025 |
| GREENFIELD INVESTMENTS LTD. | 14% | $916,700 | 515,000 | Greenfield Investments, Ltd | 13 Dec 2024 |
As of 31 Mar 2026, 18 institutional investors reported holding 826,477 shares of MANGOCEUTICALS, INC. - Common Stock, $0.0001 par value per share (MGRX). This represents 5.9% of the company’s total 14,002,438 outstanding shares.
Quarter history
Holder count, reported shares/value, and median price by quarter.
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 826,477 | $297,620 | -$1,105,675 | $0.36 | 18 |
| 2025 Q4 | 2,537,025 | $1,877,635 | +$1,555,416 | $0.74 | 18 |
| 2025 Q3 | 374,558 | $820,064 | +$209,344 | $2.19 | 11 |
| 2025 Q2 | 292,252 | $444,221 | +$326,694 | $1.52 | 10 |
| 2025 Q1 | 75,317 | $146,866 | -$46,995 | $1.95 | 8 |
| 2024 Q4 | 91,338 | $220,943 | +$216,913 | $2.42 | 9 |
| 2024 Q3 | 17,077 | $4,030 | +$4,030 | $0.24 | 1 |